OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants
Ankit Das, Niraja Ranadive, Manas Kinra, et al.
Current Neuropharmacology (2020) Vol. 18, Iss. 9, pp. 838-851
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review
Longqin Lv, Shanping Mao, Huimin Dong, et al.
Journal of Oncology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 54

Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30

Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity
Pooja Gupta, Tavneet Kaur Makkar, Lavisha Goel, et al.
Immunologic Research (2022) Vol. 70, Iss. 6, pp. 725-741
Closed Access | Times Cited: 28

Animal models of chemotherapy-induced cognitive decline in preclinical drug development
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37

CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study
Umberto Pensato, Giulia Amore, Lorenzo Muccioli, et al.
Journal of Neurology (2023) Vol. 270, Iss. 5, pp. 2659-2673
Closed Access | Times Cited: 14

Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 5

The Genomic Intersection of Oligodendrocyte Dynamics in Schizophrenia and Aging Unravels Novel Pathological Mechanisms and Therapeutic Potentials
Andrea Rivera, John R. Normanton, Arthur M. Butt, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4452-4452
Open Access | Times Cited: 4

Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access

Dopaminergic Signaling as a Plausible Modulator of Astrocytic Toll-Like Receptor 4: A Crosstalk between Neuroinflammation and Cognition
Madhavan Nampoothiri, Prasada Chowdari Gurram, Suman Manandhar, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 4, pp. 539-557
Closed Access | Times Cited: 17

Methodological shortcomings of preclinical research on chemotherapy-induced cognitive impairment
Victoria Aurora Ossorio Salazar, Rudi D’Hooge
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105198-105198
Closed Access | Times Cited: 8

Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα
Nicole Rummel, Luksana Chaiswing, Subbarao Bondada, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 19-20, pp. 6533-6540
Open Access | Times Cited: 20

Natural products for the treatment of chemotherapy-related cognitive impairment and prospects of nose-to-brain drug delivery
Yuqiong He, Cancan Zhou, Shenggui Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Exercise alleviates cisplatin-induced toxicity in the hippocampus of mice by inhibiting neuroinflammation and improving synaptic plasticity
Se Hwan Park, Jeong Rim Ko, Jin Han
Korean Journal of Physiology and Pharmacology (2024) Vol. 28, Iss. 2, pp. 145-152
Open Access | Times Cited: 2

Review of the fluoropyrimidine antidote uridine triacetate
Jack Thompson, David M. Wood, Paul I. Dargan
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 2

Transcranial Magnetic Stimulation for the Treatment of Chemo Brain
Phillip H. Kuo, Yu-Chin Chen, Rudolph J. Rodriguez, et al.
Sensors (2023) Vol. 23, Iss. 19, pp. 8017-8017
Open Access | Times Cited: 4

In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway
Arti Singh, Vishal Kumar, Urvashi Langeh, et al.
Journal of Molecular Histology (2024) Vol. 55, Iss. 4, pp. 599-625
Closed Access | Times Cited: 1

RETRACTED: Cladribine induces apoptosis, neuroinflammation, mitochondrial oxidative stress, tau phosphorylation and Aβ (1−42) pathway in the hippocampus: An in vivo approach
Khadga Raj Aran, Ghanshyam Das Gupta, Shamsher Singh
Journal of Chemical Neuroanatomy (2023) Vol. 133, pp. 102340-102340
Closed Access | Times Cited: 3

Ameliorating effect of fluoxetine on tamoxifen-induced memory loss: The role of corticolimbic NMDA receptors and CREB/BDNF/cFos signaling pathways in rats
Oveis Hosseinzadeh Sahafi, Ameneh Rezayof, Zahra Ghasemzadeh, et al.
Brain Research (2022) Vol. 1794, pp. 148058-148058
Closed Access | Times Cited: 3

Neuroprotective mechanisms and ameliorative activities of quercetin in cisplatin-induced cerebellum neurotoxicity in rat models
Sunday Aderemi Adelakun, Babatunde Ogunlade, Julius Akomaye Aniah, et al.
Brain Disorders (2024), pp. 100166-100166
Open Access

Page 1 - Next Page

Scroll to top